TTNP - TITAN PHARMACEUTICALS INC
4.61
-0.180 -3.905%
Share volume: 3,358,220
Last Updated: 10-01-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$4.79
-0.18
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 05-15-2024 | 08-15-2024 | 01-03-2025 | 03-20-2025 | 05-14-2025 | 08-14-2025 | |
| Assets | |||||||
| Total Assets | 6.646 M | 4.350 M | 3.602 M | 2.923 M | 2.156 M | 3.051 M | |
| Current Assets | 6.611 M | 4.350 M | 3.602 M | 2.923 M | 2.156 M | 3.051 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 14.000 K | 62.000 K | 81.000 K | 143.000 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 6.159 M | 4.092 M | 3.399 M | 2.831 M | 1.945 M | 2.803 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 3.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 32.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 6.646 M | 4.350 M | 3.602 M | 2.923 M | 2.156 M | 3.051 M | |
| Total liabilities | 559.000 K | 356.000 K | 371.000 K | 483.000 K | 279.000 K | 263.000 K | |
| Total current liabilities | 559.000 K | 356.000 K | 371.000 K | 483.000 K | 279.000 K | 263.000 K | |
| Accounts Payable | 371.000 K | 356.000 K | 371.000 K | 202.000 K | 194.000 K | 219.000 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 6.086 M | 3.993 M | 3.230 M | 2.439 M | 1.876 M | 2.787 M | |
| Common stock | 398.976 M | 398.976 M | 398.976 M | 398.975 M | 398.975 M | 400.575 M | |
| Retained earnings | -392.890 M | -394.983 M | -395.746 M | -396.536 M | -397.099 M | -397.788 M |